The impact of the COVID-19 pandemic on blood culture practices and bloodstream infections

ABSTRACT The COVID-19 pandemic has likely influenced the epidemiology of bacterial infections through wide-ranging changes to clinical practices and infection control and prevention interventions. We sought to determine how the detection and incidence of bloodstream infections (BSIs) have been influ...

Full description

Bibliographic Details
Main Authors: Matt Driedger, Nick Daneman, Kevin Brown, Wayne L. Gold, Sarah C.J. Jorgensen, Colleen Maxwell, Kevin L. Schwartz, Andrew M. Morris, Deva Thiruchelvam, Bradley Langford, Elizabeth Leung, Derek MacFadden
Format: Article
Language:English
Published: American Society for Microbiology 2023-12-01
Series:Microbiology Spectrum
Subjects:
Online Access:https://journals.asm.org/doi/10.1128/spectrum.02630-23
_version_ 1797393601828749312
author Matt Driedger
Nick Daneman
Kevin Brown
Wayne L. Gold
Sarah C.J. Jorgensen
Colleen Maxwell
Kevin L. Schwartz
Andrew M. Morris
Deva Thiruchelvam
Bradley Langford
Elizabeth Leung
Derek MacFadden
author_facet Matt Driedger
Nick Daneman
Kevin Brown
Wayne L. Gold
Sarah C.J. Jorgensen
Colleen Maxwell
Kevin L. Schwartz
Andrew M. Morris
Deva Thiruchelvam
Bradley Langford
Elizabeth Leung
Derek MacFadden
author_sort Matt Driedger
collection DOAJ
description ABSTRACT The COVID-19 pandemic has likely influenced the epidemiology of bacterial infections through wide-ranging changes to clinical practices and infection control and prevention interventions. We sought to determine how the detection and incidence of bloodstream infections (BSIs) have been influenced by the pandemic. We performed a retrospective analysis of blood culture data in the province of Ontario, Canada, from 1 January 2017 to 31 December 2020. Outcomes included a weekly incidence of blood culture tests, BSIs, and contaminant results. Results were stratified by hospital, community, and long-term care (LTC) settings. An interrupted time series analysis using segmented regression models was used to determine changes in outcome incidence/prevalence during the pre- and peri-pandemic periods. Of the 14,083,853 individuals included, 129,329 (0.92%) developed a bloodstream infection. The blood culture ordering rate increased during the pandemic in the hospital setting only [Incidence rate ratio (IRR) 1.09, 95% confidence interval (CI) 1.01–1.19]. There was a decline in the incidence of community-acquired (IRR 0.95, 95% CI 0.91–0.99) and LTC-acquired (IRR 0.85, 95% CI 0.76–0.94) BSIs. Hospital-acquired BSIs were unchanged. The proportion of blood culture contaminants increased in the community (7% increase, P < 0.01) and LTC settings (14% increase, P < 0.05). There was decreased incidence of community-acquired Streptococcus pneumoniae (IRR 0.43, 95% CI 0.33–0.57) and Staphylococcus aureus (IRR 0.91, 95% CI 0.84–0.99) bacteremia. Pandemic-related changes in the performance of blood cultures and the epidemiology of BSIs have implications for current and future pandemic antimicrobial use, healthcare resource allocation, and hospital and laboratory policies. IMPORTANCE Bacterial infections are a significant cause of morbidity and mortality worldwide. In the wake of the COVID-19 pandemic, previous studies have demonstrated pandemic-related shifts in the epidemiology of bacterial bloodstream infections (BSIs) in the general population and in specific hospital systems. Our study uses a large, comprehensive data set stratified by setting [community, long-term care (LTC), and hospital] to uniquely demonstrate how the effect of the COVID-19 pandemic on BSIs and testing practices varies by healthcare setting. We showed that, while the number of false-positive blood culture results generally increased during the pandemic, this effect did not apply to hospitalized patients. We also found that many infections were likely under-recognized in patients in the community and in LTC, demonstrating the importance of maintaining healthcare for these groups during crises. Last, we found a decrease in infections caused by certain pathogens in the community, suggesting some secondary benefits of pandemic-related public health measures.
first_indexed 2024-03-09T00:06:12Z
format Article
id doaj.art-5dd6ca0e7bd042199282e47d8b4c7f19
institution Directory Open Access Journal
issn 2165-0497
language English
last_indexed 2024-03-09T00:06:12Z
publishDate 2023-12-01
publisher American Society for Microbiology
record_format Article
series Microbiology Spectrum
spelling doaj.art-5dd6ca0e7bd042199282e47d8b4c7f192023-12-12T13:17:19ZengAmerican Society for MicrobiologyMicrobiology Spectrum2165-04972023-12-0111610.1128/spectrum.02630-23The impact of the COVID-19 pandemic on blood culture practices and bloodstream infectionsMatt Driedger0Nick Daneman1Kevin Brown2Wayne L. Gold3Sarah C.J. Jorgensen4Colleen Maxwell5Kevin L. Schwartz6Andrew M. Morris7Deva Thiruchelvam8Bradley Langford9Elizabeth Leung10Derek MacFadden11Department of Medicine, The University of Ottawa , Ottawa, Ontario, CanadaSunnybrook Health Sciences Centre, University of Toronto , Toronto, Ontario, CanadaPublic Health Ontario , Toronto, Ontario, CanadaThe University Health Network , Toronto, Ontario, CanadaInstitute of Medical Science , Toronto, Ontario, CanadaUniversity of Waterloo , Waterloo, Ontario, CanadaICES , Toronto, Ontario, CanadaSinai Health System , Toronto, Ontario, CanadaICES , Toronto, Ontario, CanadaPublic Health Ontario , Toronto, Ontario, CanadaUnity Health Toronto , Toronto, Ontario, CanadaDepartment of Medicine, The University of Ottawa , Ottawa, Ontario, CanadaABSTRACT The COVID-19 pandemic has likely influenced the epidemiology of bacterial infections through wide-ranging changes to clinical practices and infection control and prevention interventions. We sought to determine how the detection and incidence of bloodstream infections (BSIs) have been influenced by the pandemic. We performed a retrospective analysis of blood culture data in the province of Ontario, Canada, from 1 January 2017 to 31 December 2020. Outcomes included a weekly incidence of blood culture tests, BSIs, and contaminant results. Results were stratified by hospital, community, and long-term care (LTC) settings. An interrupted time series analysis using segmented regression models was used to determine changes in outcome incidence/prevalence during the pre- and peri-pandemic periods. Of the 14,083,853 individuals included, 129,329 (0.92%) developed a bloodstream infection. The blood culture ordering rate increased during the pandemic in the hospital setting only [Incidence rate ratio (IRR) 1.09, 95% confidence interval (CI) 1.01–1.19]. There was a decline in the incidence of community-acquired (IRR 0.95, 95% CI 0.91–0.99) and LTC-acquired (IRR 0.85, 95% CI 0.76–0.94) BSIs. Hospital-acquired BSIs were unchanged. The proportion of blood culture contaminants increased in the community (7% increase, P < 0.01) and LTC settings (14% increase, P < 0.05). There was decreased incidence of community-acquired Streptococcus pneumoniae (IRR 0.43, 95% CI 0.33–0.57) and Staphylococcus aureus (IRR 0.91, 95% CI 0.84–0.99) bacteremia. Pandemic-related changes in the performance of blood cultures and the epidemiology of BSIs have implications for current and future pandemic antimicrobial use, healthcare resource allocation, and hospital and laboratory policies. IMPORTANCE Bacterial infections are a significant cause of morbidity and mortality worldwide. In the wake of the COVID-19 pandemic, previous studies have demonstrated pandemic-related shifts in the epidemiology of bacterial bloodstream infections (BSIs) in the general population and in specific hospital systems. Our study uses a large, comprehensive data set stratified by setting [community, long-term care (LTC), and hospital] to uniquely demonstrate how the effect of the COVID-19 pandemic on BSIs and testing practices varies by healthcare setting. We showed that, while the number of false-positive blood culture results generally increased during the pandemic, this effect did not apply to hospitalized patients. We also found that many infections were likely under-recognized in patients in the community and in LTC, demonstrating the importance of maintaining healthcare for these groups during crises. Last, we found a decrease in infections caused by certain pathogens in the community, suggesting some secondary benefits of pandemic-related public health measures.https://journals.asm.org/doi/10.1128/spectrum.02630-23bloodstream infectionspandemicCOVID-19blood culturesepidemiology
spellingShingle Matt Driedger
Nick Daneman
Kevin Brown
Wayne L. Gold
Sarah C.J. Jorgensen
Colleen Maxwell
Kevin L. Schwartz
Andrew M. Morris
Deva Thiruchelvam
Bradley Langford
Elizabeth Leung
Derek MacFadden
The impact of the COVID-19 pandemic on blood culture practices and bloodstream infections
Microbiology Spectrum
bloodstream infections
pandemic
COVID-19
blood cultures
epidemiology
title The impact of the COVID-19 pandemic on blood culture practices and bloodstream infections
title_full The impact of the COVID-19 pandemic on blood culture practices and bloodstream infections
title_fullStr The impact of the COVID-19 pandemic on blood culture practices and bloodstream infections
title_full_unstemmed The impact of the COVID-19 pandemic on blood culture practices and bloodstream infections
title_short The impact of the COVID-19 pandemic on blood culture practices and bloodstream infections
title_sort impact of the covid 19 pandemic on blood culture practices and bloodstream infections
topic bloodstream infections
pandemic
COVID-19
blood cultures
epidemiology
url https://journals.asm.org/doi/10.1128/spectrum.02630-23
work_keys_str_mv AT mattdriedger theimpactofthecovid19pandemiconbloodculturepracticesandbloodstreaminfections
AT nickdaneman theimpactofthecovid19pandemiconbloodculturepracticesandbloodstreaminfections
AT kevinbrown theimpactofthecovid19pandemiconbloodculturepracticesandbloodstreaminfections
AT waynelgold theimpactofthecovid19pandemiconbloodculturepracticesandbloodstreaminfections
AT sarahcjjorgensen theimpactofthecovid19pandemiconbloodculturepracticesandbloodstreaminfections
AT colleenmaxwell theimpactofthecovid19pandemiconbloodculturepracticesandbloodstreaminfections
AT kevinlschwartz theimpactofthecovid19pandemiconbloodculturepracticesandbloodstreaminfections
AT andrewmmorris theimpactofthecovid19pandemiconbloodculturepracticesandbloodstreaminfections
AT devathiruchelvam theimpactofthecovid19pandemiconbloodculturepracticesandbloodstreaminfections
AT bradleylangford theimpactofthecovid19pandemiconbloodculturepracticesandbloodstreaminfections
AT elizabethleung theimpactofthecovid19pandemiconbloodculturepracticesandbloodstreaminfections
AT derekmacfadden theimpactofthecovid19pandemiconbloodculturepracticesandbloodstreaminfections
AT mattdriedger impactofthecovid19pandemiconbloodculturepracticesandbloodstreaminfections
AT nickdaneman impactofthecovid19pandemiconbloodculturepracticesandbloodstreaminfections
AT kevinbrown impactofthecovid19pandemiconbloodculturepracticesandbloodstreaminfections
AT waynelgold impactofthecovid19pandemiconbloodculturepracticesandbloodstreaminfections
AT sarahcjjorgensen impactofthecovid19pandemiconbloodculturepracticesandbloodstreaminfections
AT colleenmaxwell impactofthecovid19pandemiconbloodculturepracticesandbloodstreaminfections
AT kevinlschwartz impactofthecovid19pandemiconbloodculturepracticesandbloodstreaminfections
AT andrewmmorris impactofthecovid19pandemiconbloodculturepracticesandbloodstreaminfections
AT devathiruchelvam impactofthecovid19pandemiconbloodculturepracticesandbloodstreaminfections
AT bradleylangford impactofthecovid19pandemiconbloodculturepracticesandbloodstreaminfections
AT elizabethleung impactofthecovid19pandemiconbloodculturepracticesandbloodstreaminfections
AT derekmacfadden impactofthecovid19pandemiconbloodculturepracticesandbloodstreaminfections